Kidney Neoplasms D007680

Related MeSH Hierarchy (8)

Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Kidney Neoplasms

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Kidney Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urologic Neoplasms » Kidney Neoplasms

Description

Tumors or cancers of the KIDNEY.   MeSH

Hierarchy View

Subtype Terms (3)

Carcinoma, Renal Cell
493 drugs (162 approved, 331 experimental)

Wilms Tumor
82 drugs (49 approved, 33 experimental)


Phase 2 Indicated Drugs (137)


Organization Involved with Phase 3 Indications (68)

Organization Involved with Phase 2 Indications (151)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.